bezafibrate has been researched along with Stroke in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Z; Liu, B; Liu, M; Tao, W; Wang, D | 1 |
| Briel, M; Ferreira-González, I; Jakob, T; Nordmann, AJ; Schandelmaier, S | 1 |
| Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D | 1 |
| Cook, C; Cooper, J; Meade, T; Zuhrie, R | 1 |
| Hata, T; Ishikawa, K; Kitagawa, Y; Ohta, T; Shinohara, Y; Tomiyasu, H; Yamamoto, M | 1 |
| Mikhailidis, DP; Rizos, E | 1 |
| Behar, S; Benderly, M; Boyko, V; Brunner, D; Goldbourt, U; Graff, E; Mandelzweig, L; Reicher-Reiss, H; Shotan, A; Tanne, D | 1 |
3 review(s) available for bezafibrate and Stroke
| Article | Year |
|---|---|
Fibrates for secondary prevention of cardiovascular disease and stroke.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bezafibrate; Cardiovascular Diseases; Cause of Death; Cholesterol, HDL; Clofibrate; Coronary Disease; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypertriglyceridemia; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2015 |
Fibrates for primary prevention of cardiovascular disease events.
Topics: Atorvastatin; Bezafibrate; Cardiovascular Diseases; Clofibric Acid; Fenofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Middle Aged; Myocardial Infarction; Primary Prevention; Simvastatin; Stroke | 2016 |
Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?
Topics: Adult; Bezafibrate; Biomarkers; Cholesterol; Coronary Disease; Female; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Triglycerides | 2001 |
3 trial(s) available for bezafibrate and Stroke
| Article | Year |
|---|---|
Bezafibrate in men with lower extremity arterial disease: randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arteries; Bezafibrate; Coronary Disease; Double-Blind Method; Humans; Leg; Male; Middle Aged; Peripheral Vascular Diseases; Stroke; Treatment Outcome | 2002 |
Effect of anticholesterol therapy on soluble ICAM-1 in chronic stroke patients with hyperlipidemia.
Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Female; Humans; Hyperlipidemias; Intercellular Adhesion Molecule-1; Male; Pravastatin; Solubility; Stroke; Triglycerides | 2005 |
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
Topics: Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk; Severity of Illness Index; Stroke; Triglycerides | 2001 |
1 other study(ies) available for bezafibrate and Stroke
| Article | Year |
|---|---|
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke | 2002 |